189 related articles for article (PubMed ID: 18510643)
1. The spectrum of antibody-mediated renal allograft injury: implications for treatment.
Gloor J; Cosio F; Lager DJ; Stegall MD
Am J Transplant; 2008 Jul; 8(7):1367-73. PubMed ID: 18510643
[TBL] [Abstract][Full Text] [Related]
2. Clinical and pathological analyses of transplant glomerulopathy cases.
Shimizu T; Ishida H; Toki D; Nozaki T; Omoto K; Tanabe K; Honda K; Koike J
Nephrology (Carlton); 2014 Jun; 19 Suppl 3():21-6. PubMed ID: 24842817
[TBL] [Abstract][Full Text] [Related]
3. Acute Antibody-Mediated Rejection in Kidney Transplant Based on the 2013 Banff Criteria: Single-Center Experience in Uruguay.
Nin M; Coitiño R; Kurdian M; Orihuela L; Astesiano R; Garau M; López D; Rievas G; Rodriguez I; González-Martínez F; Noboa O
Transplant Proc; 2016 Mar; 48(2):612-5. PubMed ID: 27110014
[TBL] [Abstract][Full Text] [Related]
4. Sensitized renal transplant recipients: current protocols and future directions.
Gloor J; Stegall MD
Nat Rev Nephrol; 2010 May; 6(5):297-306. PubMed ID: 20234355
[TBL] [Abstract][Full Text] [Related]
5. Comparing transplant glomerulopathy in the absence of C4d deposition and donor-specific antibodies to chronic antibody-mediated rejection.
Torres IB; Salcedo M; Moreso F; Sellarés J; Castellá E; Azancot MA; Perelló M; Cantarell C; Serón D
Clin Transplant; 2014 Oct; 28(10):1148-54. PubMed ID: 25103874
[TBL] [Abstract][Full Text] [Related]
6. Early ultrastructural changes in renal allografts: correlation with antibody-mediated rejection and transplant glomerulopathy.
Haas M; Mirocha J
Am J Transplant; 2011 Oct; 11(10):2123-31. PubMed ID: 21827618
[TBL] [Abstract][Full Text] [Related]
7. Treatment of Biopsy-Proven Acute Antibody-Mediated Rejection Using Thymoglobulin (ATG) Monotherapy and a Combination of Rituximab, Intravenous Immunoglobulin, and Plasmapheresis: Lesson Learned from Primary Experience.
Zheng J; Xue W; Qing X; Jing X; Hou J; Tian X; Guo Q; He X; Cai J
Clin Transpl; 2014; ():223-30. PubMed ID: 26281149
[TBL] [Abstract][Full Text] [Related]
8. Pre-transplant donor specific anti-HLA antibody is associated with antibody-mediated rejection, progressive graft dysfunction and patient death.
Fidler SJ; Irish AB; Lim W; Ferrari P; Witt CS; Christiansen FT
Transpl Immunol; 2013 Jun; 28(4):148-53. PubMed ID: 23665534
[TBL] [Abstract][Full Text] [Related]
9. Reviewing the pathogenesis of antibody-mediated rejection and renal graft pathology after kidney transplantation.
Morozumi K; Takeda A; Otsuka Y; Horike K; Gotoh N; Narumi S; Watarai Y; Kobayashi T
Nephrology (Carlton); 2016 Jul; 21 Suppl 1():4-8. PubMed ID: 26971899
[TBL] [Abstract][Full Text] [Related]
10. Characteristics of Circulating Donor Human Leukocyte Antigen-specific Immunoglobulin G Antibodies Predictive of Acute Antibody-mediated Rejection and Kidney Allograft Failure.
Kannabhiran D; Lee J; Schwartz JE; Friedlander R; Aull M; Muthukumar T; Campbell S; Epstein D; Seshan SV; Kapur S; Sharma VK; Suthanthiran M; Dadhania D
Transplantation; 2015 Jun; 99(6):1156-64. PubMed ID: 25629531
[TBL] [Abstract][Full Text] [Related]
11. Case Report: Splenic Irradiation for the Treatment of Chronic Active Antibody-Mediated Rejection in Kidney Allograft Recipients With
Zhu L; Guo Z; Sa R; Guo H; Li J; Chen G
Front Immunol; 2021; 12():661614. PubMed ID: 33936098
[TBL] [Abstract][Full Text] [Related]
12. Non-HLA agonistic anti-angiotensin II type 1 receptor antibodies induce a distinctive phenotype of antibody-mediated rejection in kidney transplant recipients.
Lefaucheur C; Viglietti D; Bouatou Y; Philippe A; Pievani D; Aubert O; Duong Van Huyen JP; Taupin JL; Glotz D; Legendre C; Loupy A; Halloran PF; Dragun D
Kidney Int; 2019 Jul; 96(1):189-201. PubMed ID: 31005275
[TBL] [Abstract][Full Text] [Related]
13. The specificity of acute and chronic microvascular alterations in renal allografts.
Filippone EJ; Farber JL
Clin Transplant; 2013; 27(6):790-8. PubMed ID: 24118527
[TBL] [Abstract][Full Text] [Related]
14. Acute antibody-mediated rejection of renal transplant: pathogenetic and diagnostic considerations.
Truong LD; Barrios R; Adrogue HE; Gaber LW
Arch Pathol Lab Med; 2007 Aug; 131(8):1200-8. PubMed ID: 17683182
[TBL] [Abstract][Full Text] [Related]
15. Investigation of Serum Angiotensin II Type 1 Receptor Antibodies at the Time of Renal Allograft Rejection.
Lee H; Kim JI; Moon IS; Chung BH; Yang CW; Kim Y; Han K; Oh EJ
Ann Lab Med; 2015 May; 35(3):314-20. PubMed ID: 25932439
[TBL] [Abstract][Full Text] [Related]
16. Pathologic features of antibody-mediated rejection in renal allografts: an expanding spectrum.
Haas M
Curr Opin Nephrol Hypertens; 2012 May; 21(3):264-71. PubMed ID: 22388553
[TBL] [Abstract][Full Text] [Related]
17. Mechanisms of chronic renal allograft rejection. II. Progressive allograft glomerulopathy in miniature swine.
Shimizu A; Yamada K; Sachs DH; Colvin RB
Lab Invest; 2002 Jun; 82(6):673-86. PubMed ID: 12065677
[TBL] [Abstract][Full Text] [Related]
18. Durable renal response after combination of bortezomib, corticosteroids, rituximab, and plasmapheresis for late antibody-mediated renal transplant rejection
.
Ding Y; Francis J; Gautam A; Pelletier L; Sanchorawala V; Quillen K
Clin Nephrol; 2018 Apr; 89(4):252-259. PubMed ID: 29208204
[TBL] [Abstract][Full Text] [Related]
19. Antibody-mediated rejection following renal transplantation.
Sureshkumar KK; Hussain SM; Carpenter BJ; Sandroni SE; Marcus RJ
Expert Opin Pharmacother; 2007 May; 8(7):913-21. PubMed ID: 17472537
[TBL] [Abstract][Full Text] [Related]
20. Clinical Significance of HLA-DQ Antibodies in the Development of Chronic Antibody-Mediated Rejection and Allograft Failure in Kidney Transplant Recipients.
Lee H; Min JW; Kim JI; Moon IS; Park KH; Yang CW; Chung BH; Oh EJ
Medicine (Baltimore); 2016 Mar; 95(11):e3094. PubMed ID: 26986147
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
